Responses
Immunotherapy biomarkers
Original research
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
